Across TCGA pan-cancer cohorts, SRSF9P1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated SRSF9P1 data layer.
The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher SRSF9P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated SRSF9P1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and HNSC show a favorable association.
PAAD, LGG, and HNSC are the cancer types where SRSF9P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.